| Plasma membrane proteomics and its application in clinical cancer biomarker discovery R Leth-Larsen, RR Lund, HJ Ditzel Molecular & Cellular Proteomics 9 (7), 1369-1382, 2010 | 176 | 2010 |
| Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry R Leth-Larsen, R Lund, HV Hansen, AV Laenkholm, D Tarin, ON Jensen, ... Molecular & Cellular Proteomics 8 (6), 1436-1449, 2009 | 156 | 2009 |
| Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells MG Terp, KA Olesen, EC Arnspang, RR Lund, BC Lagerholm, HJ Ditzel, ... The Journal of Immunology 191 (8), 4165-4173, 2013 | 155 | 2013 |
| Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers R Lund, R Leth-Larsen, ON Jensen, HJ Ditzel Journal of proteome research 8 (6), 3078-3090, 2009 | 116 | 2009 |
| NADH-cytochrome b5 reductase 3 promotes colonization and metastasis formation and is a prognostic marker of disease-free and overall survival in estrogen receptor-negative … RR Lund, R Leth-Larsen, T Di Caterino, MG Terp, J Nissen, AV Lænkholm, ... Molecular & Cellular Proteomics 14 (11), 2988-2999, 2015 | 42 | 2015 |
| Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope‐labeled proteins of multiple histogenic origins RR Lund, MG Terp, AV Lænkholm, ON Jensen, R Leth‐Larsen, HJ Ditzel Proteomics 12 (13), 2139-2148, 2012 | 41 | 2012 |
| Identification of Markers Associated with Highly Aggressive Metastatic Phenotypes Using Quantitative Comparative Proteomics MG Terp, RR Lund, ON Jensen, R Leth-Larsen, HJ Ditzel Cancer Genomics-Proteomics 9 (5), 265-273, 2012 | 34 | 2012 |
| Monitoring process-related impurities in biologics–host cell protein analysis K Pilely, MR Johansen, RR Lund, T Kofoed, TK Jørgensen, L Skriver, ... Analytical and Bioanalytical Chemistry 414 (2), 747-758, 2022 | 29 | 2022 |
| miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant … KG Thomsen, MG Terp, RR Lund, R Søkilde, D Elias, M Bak, T Litman, ... Oncotarget 6 (30), 29224, 2015 | 23 | 2015 |
| A Novel Approach to Evaluate ELISA Antibody Coverage of Host Cell Proteins‐Combining ELISA‐based Immunocapture and Mass Spectrometry K Pilely, SB Nielsen, A Draborg, ML Henriksen, SWK Hansen, L Skriver, ... Biotechnology Progress, e2983, 2020 | 17 | 2020 |
| Using LC-MS for Efficient HCP Clearance RR Lund BIOPHARM INTERNATIONAL 33 (3), 20-21, 2020 | | 2020 |
| Host Cell Protein Analysis Strategy in Biologics Manufacturing: Analysis and Control of Process-Related Impurities E Mørtz, K Pilely, RR Lund, T Kofoed, TK Jorgensen, L Skriver An Essential Guide to Biopharmaceuticals, 2020 | | 2020 |
| An Essential Guide to Biopharmaceuticals: Chapter 10. Host Cell Protein Analysis Strategy in Biologics Manufacturing: Analysis and Control of Process-Related Impurities E Mørtz, K Pilely, RR Lund, T Kofoed, TK Jorgensen, L Skriver Nova Science Publishers, 2020 | | 2020 |
| Abstract A2-59: Resistance mechanisms to erlotinib in the non-small cell lung cancer cell line, HCC827 examined by RNA-seq K Jacobsen, N Alcaraz, RR Lund, HJ Ditzel Cancer Research 75 (22 Supplement 1), A2-59-A2-59, 2015 | | 2015 |
| Quantitative proteomics identifies central players in erlotinib resistance of the non-small cell lung cancer cell line HCC827 K Jacobsen, RR Lund, HC Beck, H Ditzel Precision Medicine for Cancer, 2015 | | 2015 |
| Identification of resistance mechanisms in erlotinib-resistant subclones of the non-small cell lung cancer cell line HCC827 by exome sequencing K Jacobsen, N Alcaraz, RR Lund, H Ditzel AACR Meeting Translation of the Cancer Genome, 2014 | | 2014 |
| Quantitative proteomics as a tool to identify resistance mechanisms in erlotinib-resistant subclones of the non-small cell lung cancer cell line HCC827 K Jacobsen 26th EORTC-NCI-AACR SYMPOSIUM, 2014 | | 2014 |
| Anti-Human CD73 Monoclonal Antibody R Leth-Larsen, R Lund, BC Lagerholm, HJ Ditzel | | 2013 |
| Proteome Analysis of Cancer Cell Lines and Tissue: PhD Thesis RR Lund Faculty of Health Sciences, University of Southern Denmark, 2011 | | 2011 |
| Absolute Quantitative Protein Profiling of Colon Tumors and Adjacent, Morphologically Normal Epithelial Tissue by Label-Free Mass Spectrometry RR Lund, RR Sprenger, TP Hansen, ON Jensen, H Ditzel CANCER PROTEOMICS-Systems Biology, Developmental Models & Data Integration, 2011 | | 2011 |
